The impact of Wnt pathway alterations including RNF43, GNAS, CTNNB1, and APC on prognosis and potential therapeutic vulnerability in pancreatic adenocarcinoma (PDAC).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: National Cancer Institute, Inova Fairfax Hospital, Pancreatic Cancer Action Network, George Mason University, Johns Hopkins University, City Of Hope National Medical Center, Rutgers Cancer Institute, Memorial Sloan Kettering Cancer Center, Cedars-Sinai Medical Center, Thomas Jefferson University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Pancreatic Cancer Action Network
OpenAlex ID: W4391096555
